文献速递神经肿瘤

胶质瘤氨基酸代谢:体内磁共振波谱检测丙氨酸作为不良生存潜在生物标志物

Amino acid metabolism in glioma: in vivo MR-spectroscopic detection of alanine as a potential biomarker of poor survival in glioma patients.
PubMed 文献 · J Neurooncol · 2024-08-27

研究在38例MRI疑似胶质瘤患者中采用短和长回波时间单 voxel PRESS MRS序列检测丙氨酸、甘氨酸、谷氨酸、谷氨酰胺和肌醇,评估其与IDH突变状态、CNS WHO分级和总生存的关系。结果显示丙氨酸检出和肌醇未检出与IDH野生型及WHO 4级显著相关,丙氨酸检出患者总生存显著更短(p=0.00002)。

要点

  • 丙氨酸检出与IDH野生型(p=0.0008)和WHO 4级(p=0.01)显著相关。
  • 肌醇未检出与IDH野生型(p=0.007)和WHO 4级(p=0.04)显著相关。
  • 丙氨酸检出患者总生存显著更短(p=0.00002)。

核心结论

  • 关注MRS中的氨基酸可提高胶质瘤的诊断和预后价值。
  • 丙氨酸即使在脂质存在下长TE时仍可见,可能是总生存的相关指标。

研究设计与样本

  • 研究纳入38例MRI疑似胶质瘤患者,使用短和长回波时间单 voxel PRESS MRS序列检测丙氨酸、甘氨酸、谷氨酸、谷氨酰胺和肌醇。
  • 评估丙氨酸、甘氨酸和肌醇的可检测性以及(谷氨酸+谷氨酰胺)/总肌酸比值与患者IDH突变状态、CNS WHO分级和总生存的关系。

主要发现

  • 丙氨酸检出与IDH野生型显著相关(p=0.0008),与WHO 4级显著相关(p=0.01)。
  • 肌醇未检出与IDH野生型显著相关(p=0.007),与WHO 4级显著相关(p=0.04)。
  • 甘氨酸检出与IDH突变状态和WHO分级均无显著关联。
  • (谷氨酸+谷氨酰胺)/总肌酸比值在WHO 4级中显著高于2级和3级。
  • 丙氨酸检出的胶质瘤患者总生存显著更短(p=0.00002)。

关键数值与推荐

  • 丙氨酸检出与IDH野生型相关(p=0.0008),与WHO 4级相关(p=0.01)。
  • 肌醇未检出与IDH野生型相关(p=0.007),与WHO 4级相关(p=0.04)。
  • (谷氨酸+谷氨酰胺)/总肌酸比值WHO 4级显著高于2级和3级。
  • 丙氨酸检出患者总生存显著更短(p=0.00002)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Reprogramming of amino acid metabolism is relevant for initiating and fueling tumor formation and growth. Therefore, there has been growing interest in anticancer therapies targeting amino acid metabolism. While developing personalized therapeutic approaches to glioma, in vivo proton magnetic resonance spectroscopy (MRS) is a valuable tool for non-invasive monitoring of tumor metabolism. Here, we evaluated MRS-detected brain amino acids and myo-inositol as potential diagnostic and prognostic biomarkers in glioma. METHOD: We measured alanine, glycine, glutamate, glutamine, and myo-inositol in 38 patients with MRI-suspected glioma using short and long echo-time single-voxel PRESS MRS sequences. The detectability of alanine, glycine, and myo-inositol and the (glutamate + glutamine)/total creatine ratio were evaluated against the patients' IDH mutation status, CNS WHO grade, and overall survival. RESULTS: While the detection of alanine and non-detection of myo-inositol significantly correlated with IDH wildtype (p = 0.0008, p = 0.007, respectively) and WHO grade 4 (p = 0.01, p = 0.04, respectively), glycine detection was not significantly associated with either. The ratio of (glutamate + glutamine)/total creatine was significantly higher in WHO grade 4 than in 2 and 3. We found that the overall survival was significantly shorter in glioma patients with alanine detection (p = 0.00002). CONCLUSION: Focusing on amino acids in MRS can improve its diagnostic and prognostic value in glioma. Alanine, which is visible at long TE even in the presence of lipids, could be a relevant indicator for overall survival.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Alcicek S, Pilatus U, Manzhurtsev A, et al. Amino acid metabolism in glioma: in vivo MR-spectroscopic detection of alanine as a potential biomarker of poor survival in glioma patients. J Neurooncol. 2024. PMID: 39192067. doi:10.1007/s11060-024-04803-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。